Cargando…
EZH2 and POU2F3 Can Aid in the Distinction of Thymic Carcinoma from Thymoma
SIMPLE SUMMARY: The morphologic distinction of thymic carcinomas from thymomas can be challenging but is important as thymic carcinomas tend to be associated with worse patient outcomes. We assessed whether immunohistochemistry for two proteins, EZH2 and POU2F3, could distinguish thymic carcinoma an...
Autores principales: | Naso, Julia R., Vrana, Julie A., Koepplin, Justin W., Molina, Julian R., Roden, Anja C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137080/ https://www.ncbi.nlm.nih.gov/pubmed/37190202 http://dx.doi.org/10.3390/cancers15082274 |
Ejemplares similares
-
SARS-CoV-2 RNA detection in Formalin-Fixed Paraffin-Embedded (FFPE) tissue by droplet digital PCR (ddPCR)
por: Majumdar, Ramanath, et al.
Publicado: (2022) -
Thymic carcinoid tumor combined with thymoma--neuroendocrine differentiation in thymoma?
por: Cho, K. J., et al.
Publicado: (1993) -
Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015) -
Imaging Evaluation of Thymoma and Thymic Carcinoma
por: Strange, Chad D., et al.
Publicado: (2022) -
CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma
por: Angirekula, Mounika, et al.
Publicado: (2022)